|
| Press Releases |
|
 |
|
| Wednesday, February 23, 2022 |
|
|
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7% |
| Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported the highest-ever revenue and profit after tax of S$205.6 million and S$39.4 million respectively for the financial year ended 31 December 2021 ("FY2021"). more info >> |
|
| Thursday, December 16, 2021 |
|
|
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide |
| Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M Dental") and 49% owned by Aoxin Q&M Dental Group Limited ("Aoxin Q&M Dental"), today announced that it has been granted a license by the Ministry of Health, Singapore to provide offsite COVID-19 polymerase chain reaction ("PCR") swab services and serology sample collection. more info >> |
|
| Friday, December 3, 2021 |
|
|
Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant |
| Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) and 49% owned by Aoxin Q&M Dental, today announced that its proprietary, locally-manufactured polymerase chain reaction ("PCR") test kits Acu-Corona 2.0 and Acu-Corona Duplex are able to detect COVID-19 positive cases infected with the Omicron variant. more info >> |
|
| Thursday, November 11, 2021 |
|
|
Q&M Dental net profit surges 154% to S$35.4M for nine months ended 30 September 2021 |
| Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported net profit after tax attributable to shareholders of S$27.3 million for the nine months ended 30 September 2021 ("9M2021"), and net profit after tax attributable to shareholders S$9.5 million for the three months ended 30 September 2021 ("3Q2021"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通、データドリブンで進めるHRBP活動による人的資本経営の実践をまとめた「CHRO Roundtable Report 2025」を発行
Aug 6, 2025 10:30: JST
|
|
|
Fujitsu's CHRO Roundtable Report 2025 highlights data-driven HRBP practices for human capital management
Aug 6, 2025 11:00 JST
|
|
|
TruMerit Launches Global Credential for First-Level, General Nurses
Aug 6, 2025 09:00 HKT/SGT
|
|
|
AITO launches EV Road Tour from Chongqing to Jakarta
Aug 6, 2025 08:00 HKT/SGT
|
|
|
AI+儲能：範式集團與海博思創成立合資公司 市場前景廣闊
Aug 6, 2025 00:08 HKT/SGT
|
|
|
NEFECON(R) Receives NMPA Approval for Production Expansion in China,as Everest Medicines Accelerates Accessibility and Capacity Efforts
Aug 5, 2025 23:22 HKT/SGT
|
|
|
港股機器人板塊升溫 首程控股領跑前線
Aug 5, 2025 23:20 HKT/SGT
|
|
|
Robot Boom in HK: Shoucheng Holdings at the Forefront
Aug 5, 2025 23:18 HKT/SGT
|
|
|
MHI Selected to Enter Next Stage Procurement Process for Australia's New General-Purpose Frigates
Aug 5, 2025 22:02 JST
|
|
|
三菱重工、豪州次期汎用フリゲートの共同開発・生産について発表
Aug 5, 2025 15:00: JST
|
|
|
AI+储能：范式集团与海博思创成立合资公司 市场前景广阔
Aug 5, 2025 14:50 HKT/SGT
|
|
|
港股机器人板块升温 首程控股领跑前线
Aug 5, 2025 14:32 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 项目完成最终可行性研究，预估内部报酬率为 145%，回本期为 11 个月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 項目完成最終可行性研究，預估內部報酬率為 145%，回本期為 11 個月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
全球首個IgA腎病對因治療藥物耐賦康®擴產獲批 雲頂新耀加速提升可及性與產能佈局
Aug 5, 2025 10:21 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
